# Fractional Flow Reserve to Determine Atherosclerosis Renovascular Hypertension Stenting

> **NCT05732077** · NA · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Renal Artery Stenosis Atherosclerotic
- Secondary Hypertension Renal Arterial

## Interventions

- **DRUG:** Dopamine
- **DIAGNOSTIC_TEST:** Fractional Flow Reserve, Renal
- **DEVICE:** Renal artery stenting

## Key facts

- **NCT ID:** NCT05732077
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-31
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05732077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05732077, "Fractional Flow Reserve to Determine Atherosclerosis Renovascular Hypertension Stenting". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05732077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*